Latest News

Press Release
November 29, 2017

TM3 Therapeutics Appoints Peter Van Vlasselaer as Chairman of the Board

Current ARMO BioSciences CEO Brings Profound Drug Development, Operations & Strategy Expertise to TM3  …
Read More
Press Release
September 13, 2017

TM3 Therapeutics Debuts with Publication of In Vivo Proof of Concept Data for Lead Compound in Treating Pantothenate Kinase-Associated Neurodegeneration

TM-1803/P-PantSAc shows potential in reducing severe outcomes of the disease; study published in Scientific Reports…
Read More